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ABSTRACT 
Objective: Long non-coding RNA’s (lncRNA’s) have a crucial role in cancer biology. In this study, the genome sequence analysis of lncRNA 
expression in autoimmune thyroid disease is done to identify novel targets for further study of the disease. 
Methods: All the data were collected from Disgenet and Ensemble genome browser. Gene ontology and network analysis were performed using the 
standard enrichment annotation method. Association of lncRNA and their targeted mRNA were analyzed by GENEMANIA. 
Results: Of the all 334 lncRNA transcripts identified, only four had coding potential. LncRNA’stranscripts ENST00000462973, ENST00000555326 
were involved in autoimmune thyroid disease pathway which corresponds to thyroid peroxidase (TPO) and thyroid-stimulating hormone 
receptor (TSHR), and this could provide better insights to therapeutics. 
Conclusion: Our current study on the potential link between lncRNAs and autoimmune thyroid disease presents a novel area for further 
investigations into the target genes of such lncRNAs, leading to therapeutic strategies for the disease. 
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INTRODUCTION 
All the genetic information related to humans is stored in the human 
genome. Human genome can be called as an elegant but cryptic store 
of information [1, 2]. With the advancement in sequencing 
technologies, better insight to human genome was well understood. 
Genomes are broadly classified into coding DNA and non-coding 
DNA [3, 4]. Coding DNA can be transcribed into mRNA and 
translated into proteins and occupy only a small fraction of the 
genome (<2%). Noncoding DNA doesn’t encode a protein and 
comprises of 98% of the genome (http://www. genome. 
gov/1201123, http://www. sanger. ac. uk/about/history/hgp/) [5, 
6]. Noncoding RNA’s can be defined as any transcript or its fragment 
which is not used as a template in ribosomal protein synthesis [7]. 
They can be used for the regulation of protein-coding genes; also, 
they play an important role in oncogenesis and tumor prognosis. In 
cellular processes such as regulation of gene expression, splicing and 
direct chemical modification are some of the functions of noncoding 
RNA’s [8-11]. 
 There are a lot number of ncRNA like transcribed ultraconserved 
region (T-UCR’s), small nucleolar RNA’s (snoRNA), PIWI-interacting 
RNA’s (piRNA), large intergenic noncoding RNA (lincRNA) and 
heterogeneous group of long noncoding RNA’s (lncRNA) [12-14]. 
They are involved in a number of human diseases which include 
neurobehavioral and developmental disorders as well as certain 
forms of cancer. Certain ncRNA’s encode to chromosomal regions 
associated with neurobehavioral disorders, including autism, 
bipolar, affective disorder and schizophrenia [15-17]. Long 
noncoding RNA’s are longer than 200nt and typically expressed in a 
developmental-specific manner. They also have short ORF size 
which is<200nt [18-20]. They exhibit low sequence conservation. 
Five different categories of classifying lncRNA are sense/antisense, 
when they overlap with the exons of a different transcript on the 
same or on the opposite strand, intronic; originating from an intron 
of a different transcript, bidirectional; when the lncRNA and an 
adjacent transcript on the opposite strand are expressed at the same 
time and intergenic when the lncRNA is located in a region not 
affected by another coding sequence [21-23]. These RNA’s are 
involved in various cellular processes including trans-regulation of 
nearby protein-coding genes, imprinting control and alternative 
splicing. LncRNA’s are associated with a number of diseases such as 
cancer, neurological disorders, heart disease and autoimmune 
disease. Based on the function lncRNA can be divided into three 
groups [24]. The first group of lncRNA’s can bind and guide cellular 
proteins towards the target. The second group of lncRNA can bind 
effector molecules and initiate the formation of specific molecular 
complexes [25-27]. The third group of lncRNA’s can bind proteins or 
RNA molecules and thus prevent these from exerting their function. 
LncRNA plays an important role in transcriptional regulation. It is a 
cellular process which includes transcriptional factor and 
polymerases to sequence-specific promoter site of genes [28]. They 
regulate the activity of transcriptional factor and polymerases. Some 
of lncRNA also act directly on transcription factors. The 
transcriptional factor is a means by which cell regulates the 
conversion of DNA to RNA [29-31].  
An example of transcriptional regulation is about PcG proteins. 
Polycomb group proteins (PcG) silence the expression of thousands 
of mammalian genes. LncRNA’s target PcG proteins to specific 
genomic locations. Ezh2 (Enhancer of zeste homolog2) a histone 
methyltransferase and member of polycomb repressive complex2 
(PRC2) bind directly to 1.6 kb-long nc RNA known as RepA. These 
lncRNA’s are active in post-transcriptional events also. Post 
transcriptional modifications include alternative splicing, editing, 
translation and trafficking. MALAT1 (Metastasis Associated Lung 
Adenocarcinoma Transcript 1) plays an important role in alternative 
splicing. The lncRNA HOTAIR (HOX transcript antisense intergenic 
RNA) is coded in the HOXC locus on chromosome 12 and regulates 
the HOXD genes on chromosome 2 by binding to the polycomb 
repressive complex PRC2 and inducing epigenetic silencing by 
methylation of several tumor suppressor genes on HOXD locus [32]. 
HOTAIR expression is deregulated in several cancers.  
The expression of HOTAIR is elevated in breast cancer which has 
been correlated with metastatic capacity and poor prognosis. 
BRCA1-binding region in the polycomb protein EZH2 overlaps with 
the noncoding RNA binding domain, and BRCA1 expression inhibits 
the binding of EZH2 to the HOTAIR. HOTAIR expression and 
metastasis have an adverse outcome in different types of cancer 
including esophageal, liver, pancreas and colorectal cancers [33]. 
Maternally expressed 3 (MEG3) is an lncRNA that is expressed in 
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normal tissues. It can activate p53 and inhibit tumor genesis and 
progression of various types of cancers. MEG3 gene expression is 
down-regulated or lost in a variety of primary human tumors and 
tumor cell lines, and re-expression of MEG3 has been shown to 
inhibit in vitro tumor cell proliferation [34-36]. Autoimmune 
diseases are caused by an immune response against constituents of 
the body’s own tissues [37]. They occur predominantly in women. 
Thyroid diseases are endocrine related problems. They emerge as 
the age increases. This occurs due to the dysfunction of the thyroid 
gland. Different thyroid diseases include Hashimoto’s thyroiditis, 
hyperthyroidism and hypothyroidism. Imbalance in the production 
of thyroid hormones arises from dysfunction of the thyroid gland 
itself. The pituitary gland produces thyroid-stimulating hormone 
(TSH) or the hypothalamus which regulates the pituitary gland via 
thyrotropin-releasing hormone. The concentration of TSH increases 
with age. Most common cause of hypothyroidism is when the body 
makes antibodies that destroy parts of the thyroid gland. Also, due 
to malfunctioning of pituitary problems, hypothalamus problems, 
and iodine deficiency this disease happens. Most common symptoms 
of hypothyroidism include coarse and dry hair, 
confusion/forgetfulness, constipation, depression, dry and scaly 
skin, fatigue, hair loss, increased menstrual flow, intolerance to cold 
temperature, irritability, muscle cramps, slower heart rate, 
weakness, weight gain. If proper treatment is not given on time, it 
can lead to a diseased state called Myxedema coma where heart 
failure can happen [38-41]. This is characterized by normal free 
thyroxin (FT4) and elevated thyrotropin (TSH) levels increase with 
aging and from 3 to 16%. Symptoms associated with 
hyperthyroidism are increased heart rate, high blood pressure, 
increased body temperature, increased sweeting, clamminess, 
feeling nervous, increased appetite accompanied by weight loss, 
interrupted sleep. In the present study, all lncRNA’s were collected 
from the genes associated with autoimmune thyroid disease. Those 
lncRNA’s which were not present in NONCOD database were filtered 
out and their gene enrichment studies were conducted. Novel 
functional lncRNA’s were identified for autoimmune thyroid disease. 
Our current study on the potential link between lncRNAs and 
autoimmune thyroid disease presents a novel area for further 
investigations into the target genes of such lncRNAs, leading to 
therapeutic strategies for the disease. 
MATERIALS AND METHODS 
Dataset 
Disgenet [42] is an open access database which is a collection of 
human disease association studies and genes associated. A key 
feature of this database is to obtain information and allows the user 
to go back to the original source of information, i.e., to explore data 
in its original context. All the genes associated with autoimmune 
thyroid disease were searched in Disgenet database. The Ensemble 
data (www. ensembl. org) was used to provide genes and other 
annotation such as regulatory regions, conserved base pairs across 
species, and sequence variations. The Ensemble gene set is based on 
protein and mRNA evidence in UniProtKB and NCBI RefSeq 
databases, along with manual annotation from the VEGA/Havana 
group. Respective transcripts were obtained from targeted genes by 
searching the gene name in ensemble database. Only lncRNA or 
processed transcripts whose length is greater than 200 nucleotides 
were sorted out and used for further analysis. 
Finding the functionally important lncRNA 
Further, a database designed to store information about non-coding 
RNA’s (excluding tRNA’s and rRNA’s) was used. Information related 
to lncRNA owing to similar alternative splicing pattern to mRNA was 
stored. There are about 210,831 number of lncRNA in NONCODE 
version 4. All the transcripts retrieved from ensemble database were 
cross-checked with the NONCODE database to find the lncRNA 
having functional importance. 
Classification of lncRNA-based on coding potential 
A Support Vector Machine-based classifier, named Coding Potential 
Calculator (CPC), is used to assess the protein-coding potential of a 
transcript based on six biologically meaningful sequence features. 
10-fold cross-validation on the training dataset and independent 
testing on three large standalone datasets showed that CPC can 
discriminate coding from noncoding transcripts with high accuracy. 
All the transcripts which were not in NONCOD database were 
checked for the non-coding efficiency. The data will be further 
classified as coding potential, weekly and non-coding potential 
transcripts. coding potential transcripts have values greater than 
zero while weekly coding will have values near to zero and non-
coding with negative values. 
Exploring the coding domains of lncRNA 
HMMER is used for searching sequence databases for homologs of 
protein sequences, and for making protein sequence alignments. It 
implements methods using probabilistic models called profile is 
hidden Markov models (profile HMMs). The advantage of using 
HMMs is that HMMs have a formal probabilistic basis. The FASTA 
sequences were obtained from the ensemble and they were 
converted to protein sequences and explored for any similar coding 
domains against pfam database. All the three open reading frames 
were checked. 
Enrichment analysis of lncRNA 
Gene ontology tool was used to perform enrichment analysis, in 
which biological meaning was assigned to a group of genes and this 
tool helps a researcher to investigate on a group of genes rather than 
a single gene. All the genes were added in the tool. Those GO terms 
which had p-value<0.05 were filtered and analyzed for biological, 
cellular and molecular ontologies. 
DAVID functional annotation cluster analysis 
The expression data was analyzed using the Functional Annotation 
Cluster (FAC) tool contained in the Database for Annotation, 
Visualization and Integrated Discovery (DAVID). As a next step, we 
used DAVID tool which helps to extract biological features/meaning 
associated with large gene lists. All the four lncRNA targeted genes 
were given to the DAVID tool. Default values were checked and other 
inputs like genetic association database disease, OMIM disease, PIR 
seq feature, SwissProt comment type, SwissProt PIR keyword, 
UniProt seq feature, GO terms, PANTHER BP pie chart (to categorize 
genes by biological processes), KEGG pathway, REACTOM pathway, 
protein domain block, InterPro, Pfam, PIR superfamily, PROSITE, 
SMART were also checked to generate related results. As a final step, 
we used GeneMANIA, a flexible, user-friendly web interface for 
generating hypotheses about gene function, analyzing gene lists and 
prioritizing genes for functional assays. GeneMANIA will output 
genes that likely are involved in the same process. 
RESULTS 
Autoimmune thyroid disease including Grave’s disease and 
Hashimoto’s thyroiditis arises due to complex interactions between 
environmental and genetic factors. Candidate gene analysis, whole-
genome linkage screening, genome-wide association studies and 
whole genome sequencing are the major technologies that have 
advanced this field. As autoimmune thyroid disease is a complex 
disorder, association studies are a major tool for identifying genes 
conferring susceptibility. Association studies can be best studied by 
DISGENET database (http://www. dis genet. org/web/ DisGeNET/ 
menu/home). All the genes and diseases associated with 
autoimmune thyroid disease (Disgenet name-autoimmune thyroid 
disease, disease id-umls: C0178468) were collected. There were 87 
genes associated with autoimmune thyroid disease and the diseases 
that share genes were 18,997. To obtain a statistically meaningful 
disease data, the 87 genes were narrowed to 25 genes based on their 
scores (table 1). The functionality of these identified lncRNA’s was 
checked from NONCOD database (table 2). Genes CTLA, TG, 
TNFRSF25, FCRL3, RBM45, ACP1, SLC26A4, THPO, HLA-DPB1, and 
CD4 have a functional lncRNA, but TSHR, PTPN22, FCRL3, FLNB, 
TRIP13, THRAP3 genes corresponding lncRNA’s are not functional. 
From the coding potential results, it was found that transcripts 
ENST00000555326, ENST00000508456, ENST00000462973, 
ENST00000478853 corresponding to TSHR, TRIP13, TPO, THRAP3 
genes have a very low coding score and they are classified as non-
coding transcripts. 32 transcripts were classified as weekly coding 
(table 3). 
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Table 1: Genes associated with autoimmune thyroid disease from disgenet 
Gene Symbol Uniprot Gene name Pathway Score 
1493 CTLA4 P16410 cytotoxic T-lymphocyte-associated 
protein 4 
Immune System 0.020 
7253 TSHR P16473 thyroid stimulating hormone receptor Signal Transduction 0.011 
7038 TG P01266 Thyroglobulin  0.009 
7173 TPO P07202 thyroid peroxidase Metabolism 0.009 
9319 TRIP13 Q15645 thyroid hormone receptor interactor 
13 
 0.008 
140805 HT  Hashimoto thyroiditis  0.008 
3126 HLA-DRB4  
 
major histocompatibility complex, class 
II, DR beta 4 
Immune System 0.005 
9967 THRAP3 Q9Y2W1 thyroid hormone receptor associated 
protein 3 
Immune System 0.005 
3133 HLA-E P13747 major histocompatibility complex, class 
I, E 
Immune System 0.004 
3123 HLA-DRB1 P01912;P01911 
Q29974 
major histocompatibility complex, class 
II, DR beta 1 
Immune System 0.003 
26191 PTPN22 Q9Y2R2 protein tyrosine phosphatase, non-
receptor type 22 (lymphoid) 
 0.003 
8718 TNFRSF25 Q93038 tumor necrosis factor receptor 
superfamily, member 25 
 0.002 
3630 INS P01308 Insulin Developmental Biology; Disease; Metabolism; 
Metabolism of proteins; Signal Transduction 
0.002 
6528 SLC5A5 Q92911 solute carrier family 5 (sodium/iodide 
cotransporter), member 5 
Metabolism; Transmembrane transport of small 
molecules 
0.002 
115352 FCRL3 Q96P31 Fc receptor-like 3  0.002 
8797 TNFRSF10A O00220 tumor necrosis factor receptor 
superfamily, member 10a 
 0.002 
129831 RBM45 Q8IUH3 RNA binding motif protein 45  0.002 
348120 LINC01193 long intergenic non-protein coding 
RNA 1193 
 0.002 
2317 FLNB O75369 filamin B, beta Immune System 0.001 
3559 IL2RA P01589 interleukin 2 receptor, alpha Immune System 0.001 
52 ACP1 P24666 acid phosphatase 1, soluble  0.001 
5172 SLC26A4 O43511 solute carrier family 26 (anion 
exchanger), member 4 
Transmembrane transport of small molecules 0.001 
920 CD4 P01730 CD4 molecule Disease; Immune System 0.001 
7066 THPO P40225 Thrombopoietin Hemostasis 0.001 
3115 HLA-DPB1 P04440 major histocompatibility complex, class 
II, DP beta 1 
Immune System 0.001 
 
Table 2: Functional lncRNA from NONCODE 
Gene ID Transcript Noncod 
CTLA CTLA4-003 ENST00000487393 NONHSAT076500 
TSHR TSHR-008 ENST00000555326  
TG TG-016 ENST00000522523  
 TG-014 ENST00000524151 NONHSAT129203 
 TG-011 ENST00000520197  
 TG-012 ENST00000519294  
TPO TPO-011 ENST00000497517  
 TPO-009 ENST00000425083  
 TPO-013 ENST00000462973  
 TPO-008 ENST00000479902  
PTPN22 PTPN22-009 ENST00000534519  
TNFRSF25 TNFRSF25-011 ENST00000475730 NONHSAT000647 
FCRL3 FCRL3-009 ENST00000473231  
 FCRL3-007 ENST00000480682  
 FCRL3-008 ENST00000494724  
 FCRL3-010 ENST00000468507  
 FCRL3-013 ENST00000457799 NONHSAT006945 
 FCRL3-012 ENST00000478179 NONHSAT006948 
RBM45 RBM45-005 ENST00000464647 NONHSAT075737 
FLNB FLNB-014 ENST00000484981  
ACP1 ACP1-010 ENST00000484464  
 ACP1-012 ENST00000484125 NONHSAT068501 
SLC26A4 SLC26A4-005 ENST00000480841  
 SLC26A4-007 ENST00000492030  
 SLC26A4-006 ENST00000460748 NONHSAT122703  
 SLC26A4-004 ENST00000497446  
 SLC26A4-003 ENST00000477350  
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THPO THPO-004 ENST00000477594 NONHSAT093713 
HLA-DPB1 HLA-DPB1-006 ENST00000471184 NONHSAT108964 
 HLA-DPB1-009 ENST00000478189 NONHSAT108966 
 HLA-DPB1-007 ENST00000498038  
 HLA-DPB1-005 ENST00000488575 NONHSAT108965 
CD4 CD4-004 ENST00000538827 NONHSAT026148 
 CD4-012 ENST00000536610 NONHSAT026146 
 CD4-011 ENST00000536563  
 CD4-008 ENST00000535466 NONHSAT026149 
 CD4-013 ENST00000535707  
 CD4-009 ENST00000536590  
TRIP13 TRIP13-003 ENST00000510412  
 TRIP13-007 ENST00000508456  
 TRIP13-005 ENST00000508430  
 TRIP13-004 ENST00000509210  
THRAP3 THRAP3-005 ENST00000466743  
All the lncRNA’s translated information was obtained in all three reading frames. It was sent to HMMER tool to see if these lncRNA’s do not have a 
common protein-coding region (table 4). To obtain the functional aspects of genes encoded by lncRNA, gene enrichment analysis was done. Gene 
ontology and DAVID (Database for Annotation, Visualization, and Integrated Discovery) were used. From the DAVID analysis, we got two functional 
annotation clusters having respective enrichment score 0.35 and 0.13. The greater enrichment value more refined the results are. For further 
analysis of the genes, we went for annotation cluster 1. Out of four genes, three genes THRAP3, TPO, TSHR share alternative splicing, splice variants, 
alternative products as the functional category (table 5, 6). While lncRNA’s have the property of alternative splicing and thus these three genes may 
have the potential to regulate transcription. Also, the fold enrichment values were also less than 2. From the functional annotation table, terms 
having p-value<0.05 showed genes related to thyroid and related terms. 
 
Table 3: Noncoding RNA’s from coding potential calculator score 
Name Transcript ID CPC Score CPC Task ID 
TSHR-008 ENST00000555326 -0.719541 ACCECF50-C342-11E4-8340-80687D09C235 
TRIP13-007 ENST00000508456 -1.08334 73B0ED90-BC2E-11E4-8340-EC199BD12F24 
TPO-013 ENST00000462973 -1.16605 236CEE90-BC4E-11E4-8340-B2BE43EA36D5 
THRAP3-003 ENST00000478853 -1.11326 13741A70-BCEB-11E4-8340-A4563B8E59E1 
 
Table 4: Functional annotation cluster1 from DAVID 
Annotation cluster 1 Enrichment score 0.35 







3 75 0.3366 TPO, TSHR, 
TRIP13 
4 1.926582 0.999999 0.999727 
UP_SEQ_FEATURE splice variant 3 75 0.3379 TPO, TSHR, 
TRIP13 
4 1.922066 0.999993 0.999993 
SP_COMMENT_TYPE alternative 
products 
3 75 0.3433 TPO, TSHR, 
TRIP13 
4 1.903523 0.998181 0.957356 
SP_COMMENT_TYPE similarity 3 75 0.9809 TPO, TSHR, 
TRIP13 
4 0.817050 1 0.999949 
 
Table 5: Functional annotation cluster2 from DAVID 
Annotation  cluster 2 Enrichment score-0.13 





sp_pir_keywords polymorphism 3 75 0.648681 THRAP3, TPO, 
TSHR 
4 1.249025 1 0.999999 
up_seq_feature sequence variant 3 75 0.687010 THRAP3, TPO, 
TSHR 
4 1.195359 1 0.999999952 
sp_comment_type function 3 75 0.783241 THRAP3, TPO, 
TSHR 
4 1.072366 1 0.996764727 
sp_comment_type subcellular 
location 
3 75 0.832350 THRAP3, TPO, 
TSHR 
4 1.013532816 1 0.995288005 
 
Heat map results showed thyroid peroxidase, thyroid 
stimulating hormone receptor, thyroid hormone receptor 
interactor 13 taking part in alternative splicing events (fig. 1). 
From the functional annotation table, KEGG pathway results 
showed that lncRNA targeted genes TPO and TSHR were there in 
the pathway represented. The marked red genes in the pathway 
(shown in below fig. 2) are involved in a pathway associated 
with thyroid disease. 
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Fig. 1: Heat map generated for cluster1 
 
Table 6: Functional annotation table from DAVID 
Category Term P-value Genes Bonferroni Benjamini 
sp_pir_keywords thyroid gland 0.0006 TPO, TSHR 0.0246 0.0246 
sp_pir_keywords congenital hypothyroidism 0.0009 TPO, TSHR 0.0367 0.0185 
genetic_association_db_disease Hypothyroidism 0.0033 TPO, TSHR 0.0640 0.0640 
kegg_pathway hsa05320:Autoimmune thyroid disease 0.0100 TPO, TSHR 0.0586 0.0586 
sp_comment alternative products: Additional isoforms seem to 
exist 
0.0369 TPO, TSHR 0.7606 0.76065 
goterm_bp_fat GO: 0006366~transcription from RNA polymerase 
II promoter 
0.05100 THRAP3, TRIP13 0.9990 0.9990 
sp_comment_type sequence caution 0.0570 THRAP3, TSHR, 
TRIP13 
0.5858 0.5858 
goterm_bp_fat GO: 0006351~transcription, DNA-dependent 0.0633 THRAP3, TRIP13 0.9998 0.9871 
goterm_bp_fat GO: 0032774~RNA biosynthetic process 0.0642 THRAP3, TRIP13 0.9998 0.9472 
goterm_mf_fat GO: 0003712~transcription cofactor activity 0.0815 THRAP3, TRIP13 0.9570 0.9570 
sp_pir_keywords transmembrane protein 0.0968 TPO, TSHR 0.9829 0.7428 
 
 
Fig. 2: Pathway of autoimmune thyroid disease from KEGG (kyoto encyclopedia of genes and genomes, http://www. genome. jp/kegg/) 
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Fig. 3: GeneMANIA interaction diagram autoimmune thyroid disease (http://www.genemania.org/) 
 
Four differently transcribed mRNA’s regulated by lncRNA, including 
TSHR, TPO, THRAP3, TIRAP3 were subjected to GENEMANIA 
analysis (fig. 3). Three TSHR, TPO and TRIP13 were found to be in a 
functional network in terms of co-expression. Also, TSHR, TRIP13 
and THRAP3 are involved in physical interactions.  
 
 
Fig. 4: Gene ontology for biological process 
(http://geneontology.org) 
 
All the genes were showing biological significance and 56.18% 
showing the metabolic process. There are seven ontologies 
associated with the biological process (fig. 4). 100% of genes 
corresponds biological process, then metabolic process and finally 
cellular process. Other ontologies associated are a single-organism 
process, primary metabolic process, organic substance metabolic 
process and cellular metabolic process. The function carried out by the 
genesis tetrapyrrole binding. This refers to molecular ontology (fig. 5). 
Molecular ontology illustrates seven top ten ontologies which have 
tetrapyrrole binding with 36%, heme binding 33%, antioxidant 
activity 13%, oxidoreductase active acting on peroxide as receptor 
8%, and peroxidase activity 7%. There are nine ontology terms 
associated with the cellular process, and 21% of genes are involved 
in cellular processes (fig. 6), 14% in the cell, and 13% in cell part, 
intracellular part, an integral component of the membrane and 
intrinsic component of cell membrane. From the cellular process, it 
was found that most of the gene product functions are related to cell. 
GO analyses predicted that lncRNAs targeted mRNA were associated 
with the metabolic process (ontology: biological process), cell 
(ontology: cellular component) and binding (ontology: molecular 
function). 
DISCUSSION 
In recent years, there were a lot of evidence supporting lncRNA’s 
associated with cancer. However, very few studies have been 
conducted on the potential role of lncRNA’s in autoimmune diseases. 
Investigations into the molecular mechanism of the autoimmune 
disease especially thyroid diseases have focused only on protein 
coding part. Therefore, our understanding of lncRNA function in 
autoimmune thyroid disease is poor. For this reason, current study 
focusses on non-coding part (lncRNA) for further investigation of 
the therapeutic potential of autoimmune thyroid disease. Since long 
non-coding RNA’s fall under the transcriptome study, it was 
necessary to find the corresponding transcripts from the gene 
associated. For lncRNA transcriptome study, more emphasis was 
given on the reference database used. In this study, ensemble project 
and related annotation from the Biomart/Havana group at Sanger 
Institute provide effective identification, classification, and counting 
of differentially expressed non-coding transcriptome associated 
with autoimmune thyroid disease.  
All the associated transcripts of autoimmune thyroid disease from 
genes were retrieved from the ensemble gene browser 
(http://www.ensembl.org/index.html). There were 1711 transcripts 
identified from 25 genes which included both protein-coding and 
non-coding transcripts. As our interest was on lncRNA which comes 
under non-coding part, the results were filtered, and 334 transcripts 
were identified. The non-coding part contains processed not only 
transcripts/lncRNA but also 23 retained introns, 1 pseudogene, 18 
processed transcripts, 15 nonsense-mediated decay, 209 known 
protein-coding transcripts, 18 novel protein-coding transcripts and 
25 putative protein coding transcripts. retained introns are 
alternatively spliced transcript that is believed to contain intronic 
sequence relative to other coding transcripts in a given locus, 
nonsense-mediated decay is a process which detects nonsense 
mutations and prevents the expression of truncated proteins, novel 
protein coding transcripts are having a sequence matched outside 
Ensemble for an alternate species and known protein-coding 
transcripts have a sequence match in a sequence repository external 
to Ensemble for same species. 
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Fig. 5: Gene ontology for molecular process (http://geneontology.org) 
 
 
Fig. 6: Gene ontology for cellular process (http://geneontology.org) 
 
In this study, we identified 1711 protein transcripts from 25 genes 
related to autoimmune thyroid disease. Of these 334 transcripts 
contained lncRNA’s which were greater than 200nt. Unlike protein-
coding gene or miRNA’s the function of lncRNA’s cannot be currently 
inferred from sequence/structure. Therefore, to date, most of the studies 
have predicted function via, a genomic association of lncRNA’s with 
protein-coding genes because lncRNA’s often regulate the expression of 
their overlapping or neighboring protein-coding genes [19]. 
To further define the biological processes lncRNA’s may be involved 
in, gene ontology enrichment analysis was done with a protein 
coding genes associated with lncRNA’s in genomic content. GO 
analysis predicted that lncRNA’s targeted mRNA were associated 
with the metabolic process (ontology: biological), cell (ontology: 
cellular) and binding (ontology: molecular). Similar studies were 
done with hepatoblastoma tissues [36]. 
With the four lncRNA targeted genes, functional annotation 
clustering was done with DAVID with default GO term libraries. 
Parameters were set with high stringency and ease=0.1. The rank of 
the four impacted GO biological processes, GO molecular function, 
Swiss-prot (SP) and protein information resource (PIR) keywords 
(SP_PIR_KEYWORD) show that the lncRNA targeted genes was able 
to capture GO biological processes which can be easily expected in 
transcription from RNA polymerase II promoter which had p-
value<0.05 [44]. 
To check the regulating mRNA’s associated with lncRNA, all the 
genes were given to GENEMANIA software [43]. Three TSHR, TPO 
and TRIP13 were found to be in a functional network in terms of co-
expression. Also, TSHR, TRIP13 and THRAP3 are involved in 
physical interactions and it constitutes around 64% of the 
interactions. THRAP3 is involved with exon-exon junction complex 
and regulation of alternative mRNA splicing via spliceosome. TPO 
have the function like hormone metabolic process, thyroid hormone 
generation, thyroid hormone metabolic process, phenol containing 
metabolic process which can be more relevant to our study [20]. 
The data from the current study shows that expression of this 
altered lncRNAs could contribute to autoimmune thyroid disease 
therapeutics. To understand the functions of lncRNAs further, in the 
current study pathway analysis was used to associate these 
differentially expressed lncRNAs with their target genes and found 
that one pathway corresponded to transcripts; the most enriched 
network was autoimmune thyroid regulation composed of two 
targeted genes.  
CONCLUSION  
A total of 334 processed transcripts/lncRNA’s were identified, only 
four of them ENST00000555326, ENST00000508456, ENST0000-
0462973, ENST00000478853 corresponding to TSHR, TRIP13, TPO, 
THRAP3 had coding potential. These lncRNA transcripts 
ENST00000555326, ENST00000462973 were involved in 
autoimmune thyroid disease pathway. The data from the current 
study shows that expression of these lncRNAs could contribute to 
autoimmune thyroid disease. Our current study on the potential link 
between lncRNAs and autoimmune thyroid disease presents a novel 
area for further investigations into the target genes of such lncRNAs, 
leading to therapeutic strategies for the disease. 
Sugumar et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 6, 142-150 
149 
ACKNOWLEDGMENT 
The authors thank the management of SRM University for providing 
the facilities to carry out this work. 
CONFLICTS OF INTERESTS 
There is no potential conflict of interest or competing interest. 
REFERENCES 
1. Wilson BJ, Nicholls SG. The human genome project and recent 
advances in personalized genomics. J Risk Management 
Healthcare Policy 2015;8:9. 
2. Shendure J, Mitra RD, Varma C, Church GM. Advanced 
sequencing technologies: methods and goals. Nat Rev Genet 
2004;5:335-44. 
3. Hernandez LM. editor. Diffusion and Use of Genomic 
Innovations in Health and Medicine: Workshop Summary. 
National Academies Press; 2008. 
4. De Vargas AF. The human genome project and its importance in 
clinical medicine. Int Congr Ser 2002;1237:3-13. 
5. National Human Genome Research Institute, USA, est; 1989. 
Available from: http://www.genome.gov/12011238. [Last 
accessed on 10 Jan 2016]. 
6. Wellcome trusts Sanger institude. The human genome project. 
Available from: https://www.sanger.ac.uk/about/history/ 
hgp/. [Last accessed on 10 Jan 2016]. 
7. Louro R, El-Jundi T, Nakaya HI, Reis EM, Verjovski-Almeida S. 
Conserved tissue expression signatures of intronic noncoding 
RNAs transcribed from human and mouse loci. Genomics 
2008;92:18-25. 
8. Wong DT. Salivary extracellular noncoding RNA: emerging 
biomarkers for molecular diagnostics. Clin Ther 2015;37:540-51. 
9. Koshimizu TA, Fujiwara Y, Sakai N, Shibata K, Tsuchiya H. 
Oxytocin stimulates expression of a noncoding RNA tumor 
marker in a human neuroblastoma cell line. Life Sci 
2010;86:455-60. 
10. Szymanski M, Barciszewska MZ, Erdmann VA, Barciszewski J. A 
new frontier for molecular medicine: noncoding RNAs. Biochim 
Biophysica Acta (BBA)-Rev Cancer 2005;1756:65-75. 
11. Storz G, Opdyke JA, Zhang A. Controlling mRNA stability and 
translation with small, noncoding RNAs. Curr Opin Microbiol 
2004;7:140-4. 
12. Vogel J, Wagner EG. Target identification of small noncoding 
RNAs in bacteria. Curr Opin Microbiol 2007;10:262-70. 
13. Li C, Li Y, Shen L, Huang J, Sun Y, Luo Y, et al. The role of 
noncoding regions of classical swine fever virus C-strain in its 
adaptation to the rabbit. Virus Res 2014;183:117-22. 
14. Santosh B, Varshney A, Yadava PK. Non-coding RNAs: biological 
functions and applications. Cell Biochem Function 2015;33:14-22. 
15. Alvarez ML, DiStefano JK. The role of non-coding RNAs in 
diabetic nephropathy: potential applications as biomarkers for 
disease development and progression. Diabetes Res Clin Pract 
2013;99:1-11. 
16. Fu M, Huang G, Zhang Z, Liu J, Huang Z, Yu B, et al. Expression 
profile of long noncoding RNAs in cartilage from knee 
osteoarthritis patients. Osteoarthritis Cartilage 2015;23:423-32. 
17. Beltrami C, Angelini TG, Emanueli C. Noncoding RNAs in diabetes 
vascular complications. J Mol Cell Cardiol 2015;89:42-50. 
18. Lv J, Liu H, Huang Z, Su J, He H, Xiu Y, et al. Long non-coding 
RNA identification over mouse brain development by 
integrative modeling of chromatin and genomic features. 
Nucleic Acids Res 2013;41:10044-61. 
19. Sun J, Lin Y, Wu J. Long non-coding RNA expression profiling of 
mouse testis during postnatal development. PloS One 
2013;8:750-7. 
20. Luo X, Pan J, Wang L, Wang P, Zhang M, Liu M, et al. Epigenetic 
regulation of lncRNA connects ubiquitin-proteasome system 
with infection-inflammation in preterm births and preterm 
premature rupture of membranes. BMC Pregnancy Childbirth 
2015;15:21. 
21. Xin M, Wang Y, Yao Y, Song N, Hu Z, Qin D, et al. Identification 
and characterization of wheat long non-protein coding RNAs 
responsive to powdery mildew infection and heat stress by 
using microarray analysis and SBS sequencing. BMC Plant Biol 
2011;11:61. 
22. Hao Y, Wu W, Shi F, Dalmolin RJ, Yan M, Tian F, et al. Prediction 
of long noncoding RNA functions with co-expression network 
in esophageal squamous cell carcinoma. BMC Cancer 
2015;15:1. 
23. Isin M, Dalay N. LncRNAs and neoplasia. Clin Chim Acta 
2015;444:280-8. 
24. Parolia A, Crea F, Xue H, Wang Y, Mo F, Ramnarine VR, et al. The 
long non-coding RNA PCGEM1 is regulated by androgen 
receptor activity in vivo. Mol Cancer 2015;14:1. 
25. Gao W, Zhu M, Wang H, Zhao S, Zhao D, Yang Y, et al. 
Association of polymorphisms in long non-coding RNA H19 
with coronary artery disease risk in a Chinese population. 
Mutat Res 2015;772:15-22. 
26. Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, Wang Y, et al. The long 
non-coding RNA HOTTIP promotes progression and 
gemcitabine resistance by regulating HOXA13 in pancreatic 
cancer. J Transl Med 2015;13:84. 
27. Zhao W, Mu Y, Ma L, Wang C, Tang Z, Yang S, et al. Systematic 
identification and characterization of long intergenic non-
coding RNAs in fetal porcine skeletal muscle development. Sci 
Rep 2015;5. Doi:10.1038/srep08957. [Article in Press] 
28. Gibb EA, Brown CJ, Lam WL. The functional role of long non-
coding RNA in human carcinomas. Mol Cancer 2011;10:1-38. 
29. Han D, Wang M, Ma N, Xu Y, Jiang Y, Gao X. Long noncoding 
RNAs: novel players in colorectal cancer. Cancer Lett 
2015;361:13-21. 
30. Haemmerle M, Gutschner T. Long non-coding RNAs in cancer 
and development: where do we go from here? Int J Mol Sci 
2015;16:1395-405. 
31. Villegas VE, Zaphiropoulos PG. Neighboring gene regulation by 
antisense long non-coding RNAs. Int J Mol Sci 2015;16:3251-66. 
32. Kornienko AE, Guenzl PM, Barlow DP, Pauler FM. Gene 
regulation by the act of long non-coding RNA transcription. 
BMC Biol 2013;11:1. 
33. Loewen G, Jayawickramarajah J, Zhuo Y, Shan B. Functions of 
lncRNA HOTAIR in lung cancer. J Hematol Oncol 2014;7:90. 
34. Zhang YC, Liao JY, Li ZY, Yu Y, Zhang JP, Li QF, et al. Genome-
wide screening and functional analysis identifies a large 
number of long noncoding RNAs involved in the sexual 
reproduction of rice. Genome Biol 2014;15:512. 
35. Xu G, Chen J, Pan Q, Huang K, Pan J, Zhang W, et al. Long 
noncoding RNA expression profiles of lung adenocarcinoma 
ascertained by microarray analysis. PloS One 2014;9:e104044. 
Doi:10.1371/journal.pone.0104044. [Article in Press] 
36. Dong R, Jia D, Xue P, Cui X, Li K, Zheng S, et al. Genome-wide 
analysis of long noncoding RNA (lncRNA) expression in 
hepatoblastoma tissues. PloS One 2014;9:e85599. 
Doi:10.1371/journal.pone.0085599. [Article in Press] 
37. Pearce SH, Merriman TR. Genetics of type 1 diabetes and 
autoimmune thyroid disease. Endocrinol Metab Clin North Am 
2009;38:289-301. 
38. Taylor JC, Gough SC, Hunt PJ, Brix TH, Chatterjee K, Connell JM, 
Franklyn JA, et al. A genome-wide screen in 1119 relative pairs 
with autoimmune thyroid disease. J Clin Endocrinol Metab 
2006;91:646-53. 
39. Ban Y, Ban Y, Ban Y. Autoimmune thyroid disease genes 
identified in non-caucasians. Open J Endocr Metab Dis 
2012;2:107-16.  
40. Shiva S, Ilkhchooyi F, Rezamand A. Thyroid autoimmunity at 
the onset of type 1 diabetes mellitus in children. Open J 
Immunol 2013;3:37-40. 
41. Gesing A, Lewiński A, Karbownik-Lewińska M. The thyroid 
gland and the process of aging; what is new? Thyroid Res 
2012;5:1-5. 
42. Bauer-Mehren A, Bundschus M, Rautschka M, Mayer MA, Sanz 
F, Furlong LI. Gene-disease network analysis reveals functional 
modules in mendelian, complex and environmental diseases. 
PloS One 2011;6:e20284. Doi:10.1371/journal.pone.0020284. 
[Article in Press] 
43. Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, Donaldson 
SL, et al. GeneMANIA cytoscape plugin: fast gene function 
predictions on the desktop. Bioinformatics 2010;26:2927-8. 
Sugumar et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 6, 142-150 
150 
44. Bionaz M. Nutrigenomics approaches to fine-tune metabolism 
and milk production: is this the future of ruminant nutrition? 
Adv Dairy Res 2014;2:e107. Doi:10.4172/2329-888X. 
1000e107. [Article in Press]. 
 
